These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 7587700

  • 1. [The preventive recurrent results of postoperative intravesical instillation therapy in bladder cancer].
    Zhang S, Li H, Cheng H.
    Zhonghua Wai Ke Za Zhi; 1995 May; 33(5):304-6. PubMed ID: 7587700
    [Abstract] [Full Text] [Related]

  • 2. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ, Shen ZJ, Lu J, Jin XD, Chen J, Shi SF.
    Zhonghua Wai Ke Za Zhi; 2005 Nov 15; 43(22):1457-60. PubMed ID: 16318813
    [Abstract] [Full Text] [Related]

  • 3. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH, Ye G, Wang XW, Jin HS, Zhang YN, Yan ZL.
    Ai Zheng; 2008 Nov 15; 27(11):1208-11. PubMed ID: 19000455
    [Abstract] [Full Text] [Related]

  • 4. [Prophylactic effects of zhuling and BCG on postoperative recurrence of bladder cancer].
    Yang DA, Li SQ, Li XT.
    Zhonghua Wai Ke Za Zhi; 1994 Jul 15; 32(7):433-4. PubMed ID: 7842985
    [Abstract] [Full Text] [Related]

  • 5. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.
    Volkmer BG, Gschwend JE, Maier SH, Seidl-Schlick EM, Bach D, Romics I.
    J Urol; 2003 Mar 15; 169(3):931-4; discussion 934-5. PubMed ID: 12576815
    [Abstract] [Full Text] [Related]

  • 6. [Intravesical BCG therapy for superficial bladder cancer].
    Segawa N, Iwamoto Y, Azuma H, Yamamoto K, Ueda H, Katsuoka Y.
    Hinyokika Kiyo; 1998 Sep 15; 44(9):627-31. PubMed ID: 9805666
    [Abstract] [Full Text] [Related]

  • 7. Immunoprophylaxis of superficial bladder cancer: a prospective and randomized comparison of oral versus intravesical Bacillus Calmette-Guerin.
    Netto Júnior NR, Levi d'Ancona CA, Claro JF, Ilari O.
    Arch Esp Urol; 1991 Oct 15; 44(8):1025-8. PubMed ID: 1796850
    [Abstract] [Full Text] [Related]

  • 8. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
    Peyromaure M, Guerin F, Amsellem-Ouazana D, Saighi D, Debre B, Zerbib M.
    J Urol; 2003 Jun 15; 169(6):2110-2. PubMed ID: 12771729
    [Abstract] [Full Text] [Related]

  • 9. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr 15; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 10. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol; 2009 Mar 15; 16(3):279-86. PubMed ID: 19207609
    [Abstract] [Full Text] [Related]

  • 11. Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer.
    Demkow T, Alter A, Wiechno P.
    Urol Int; 2008 Mar 15; 80(1):74-9. PubMed ID: 18204238
    [Abstract] [Full Text] [Related]

  • 12. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY, Shipley WU, Dahl DM, Coen JJ, Heney NM, Kaufman DS, Zietman AL.
    BJU Int; 2009 Jul 15; 104(2):179-83. PubMed ID: 19154448
    [Abstract] [Full Text] [Related]

  • 13. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y, Oogo Y, Takase K, Hamano A, Yamashita Y, Noguchi S, Satomi Y.
    Hinyokika Kiyo; 2004 Nov 15; 50(11):767-71. PubMed ID: 15628536
    [Abstract] [Full Text] [Related]

  • 14. [Mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2].
    Wen R, Zhou G, Xie S, Lian B, Sun X, Chen J.
    Zhonghua Wai Ke Za Zhi; 1998 Apr 15; 36(4):247-8. PubMed ID: 11825381
    [Abstract] [Full Text] [Related]

  • 15. [Long-term results of intravesical N-CWS instillation to prevent recurrence after surgery for bladder cancer].
    Chen S, Lin Z, Xu E.
    Zhonghua Zhong Liu Za Zhi; 1997 May 15; 19(3):228-30. PubMed ID: 10920905
    [Abstract] [Full Text] [Related]

  • 16. [Our experience in treating patients with surface cancer of the bladder].
    Matveev BP, Figurin KM, Romanov VA, Cheban NL.
    Urol Nefrol (Mosk); 1995 May 15; (5):35-8. PubMed ID: 8571484
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar 15; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F, Schuster F.
    Aktuelle Urol; 2005 Aug 15; 36(4):337-41. PubMed ID: 16110407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.